Ads
related to: long acting bronchodilator names list- Dosing Information
HCPs: See The Dosing Information Of
This Once-Daily Asthma Inhaler.
- Adverse Reactions
Learn About The Adverse Reactions
Of This Daily Asthma Treatment.
- Samples & Savings
Request Samples For Your Practice
Daily Triple Therapy Asthma Option.
- Formulary Coverage
See If Your Patients Are Covered
With This Daily Asthma Treatment.
- Resources & Information
Access Resources & Important Info
For An Asthma Therapy Here.
- Important Safety Info
Read About Safety & Side Effects
For An Asthma Triple Therapy.
- Dosing Information
Search results
Results From The WOW.Com Content Network
Short-acting medications provide quick or "rescue" relief from acute bronchoconstriction. Long-acting bronchodilators help to control and prevent symptoms. The three types of prescription bronchodilating drugs are beta-2 adrenergic agonists (short- and long-acting), anticholinergics (short- and long-acting), and theophylline (long-acting).
2 Bronchodilators. 3 Anti-hypertensives. 4 Anti-inflammatories. ... A list of drugs or therapeutic agents administered via inhalation. Inhalational anesthetic agents
Formoterol, also known as eformoterol, is a long-acting β 2 agonist (LABA) used as a bronchodilator in the management of asthma and chronic obstructive pulmonary disease (COPD). Formoterol has an extended duration of action (up to 12 h) compared to short-acting β 2 agonists such as salbutamol (albuterol), which are effective for 4 h to 6 h.
On 18 November 2005, the U.S. Food and Drug Administration (FDA) alerted healthcare professionals and patients that several long-acting bronchodilator medicines have been associated with possible increased risk of worsening wheezing in some people, and requested that manufacturers update warnings in their existing product labeling.
The following is a list of key pharmaceuticals in the prevention and treatment of respiratory-related ailments. Adrenergic (Sympathomimetic) Bronchodilators [ edit ]
Umeclidinium bromide is a long-acting muscarinic antagonist. [14] This combination was approved by the FDA on December 18, 2013 [15] for the long-term maintenance treatment of COPD. On March 28, 2014, it was approved in European countries [16] and in Russia [17] under the same trade name.
Ad
related to: long acting bronchodilator names list